Natura Cosméticos (NATU3) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3-26 net revenue was BRL 5.038bn, down 3.0% YoY in BRL and 5.9% at constant currency; Brazil’s operating bottlenecks outweighed near-flat Hispanic revenue in constant currency.
9M 2026 consolidated net revenue was R$14,953,175 thousand and net loss was R$360,409 thousand; 2025 comparability is affected by the merger accounting perimeter.
Q3 EBITDA was BRL 460mn at a 9.1% margin; net income was BRL 49mn versus a BRL 119mn loss from continuing operations in Q3-25. Net debt fell to BRL 3.422bn and leverage improved to 1.83x.
Financial highlights
9M net revenue was BRL 14.953bn, down 6.7% YoY; EBITDA was BRL 1.425bn, down 19.6%, with margin at 9.5%, down 160 bps.
Q3 gross margin was 65.7%, down 150 bps YoY; selling expenses were flat in BRL and G&A fell 19.7%.
Q3 net financial results improved BRL 164mn YoY to a BRL 267mn expense; 9M consolidated financial result was an expense of R$1,092,281 thousand versus R$739,225 thousand in 9M 2025.
Q3 FCFF was BRL 268mn versus BRL 10mn in Q3-25; 9M consolidated operating cash flow was R$1,826,753 thousand and investing cash flow was an outflow of R$573,706 thousand.
Consolidated cash and cash equivalents were R$2,570,876 thousand at September 30, 2026, versus R$1,490,706 thousand at December 31, 2025.
Segment performance
Brazil revenue fell 9.0% YoY in Q3, improving from Q2’s 14.8% decline but below expectations; product shortages and a smaller, less active consultant base constrained sales.
Brazil EBITDA was BRL 304mn at a 10.4% margin, down 330 bps YoY; marketing, operating deleverage, inventory write-offs and severance costs outweighed G&A savings.
Hispanic revenue rose 6.7% in BRL but declined 0.9% in constant currency; Mexico faced unfavorable phasing, fewer consultants and supply constraints, while Argentina’s recovery remained slow.
Hispanic EBITDA was BRL 109mn at a 5.2% margin, up 230 bps YoY; excluding identified non-operating effects, EBITDA would have been BRL 250mn and margin 11.8%.
9M revenue was R$8,671,600 thousand in Brazil and R$6,281,575 thousand in Hispanic America; management reports one operating segment with geographic views.
Latest events from Natura Cosméticos
- Revenue fell 9.1% YoY as Brazil struggled, but Hispanic markets grew and cash flow stayed strong.NATU3
Q2 2026 - Net revenues fell 7.7% YoY and net loss widened to BRL 445 million amid restructuring costs.NATU3
Q1 2026 - Underlying EBITDA margin rose to 14.1% in FY25, with net income at BRL 974 million.NATU3
Q4 2025 - Q3-25 revenue fell 13.1% YoY, with profitability pressured by macro and integration headwinds.NATU3
Q3 2025 - Recurring EBITDA margin rose to 14.0% and net income turned positive amid major restructuring.NATU3
Q2 2025 - Core strengths, digitalization, and integration drive growth and profitability in Latin America.NATU3
Investor Day 2025 - Recurring EBITDA up 52% YoY, but API deconsolidation drove a BRL 6.7bn net loss.NATU3
Q3 2024 - Latam growth and margin gains drove Q1-25 revenue to BRL 6.7B, offsetting Avon's challenges.NATU3
Q1 2025 - Q4-24 net revenue up 16.1% YoY, recurring EBITDA margin down 70 bps, FY24 net loss BRL 8.9bn.NATU3
Q4 2024